Literature DB >> 2249657

Negative autoregulation of c-myc gene expression is inactivated in transformed cells.

F Grignani1, L Lombardi, G Inghirami, L Sternas, K Cechova, R Dalla-Favera.   

Abstract

Negative feedback regulation of c-myc gene expression has been observed in some, but not all, cell types. In order to demonstrate conclusively the existence of this mechanism and gain insight into the cause of its inactivation, we have directly examined its function in B cells and then investigated its activity in a number of cell types. We demonstrate the existence of negative c-myc autoregulation by showing the rapid, dose dependent and reversible suppression of endogenous c-myc expression in EBV-immortalized B lymphoblastoid cells transfected with a c-myc gene expressed under the control of a heavy metal inducible promoter. Autoregulation occurs at the level of transcriptional initiation and is mediated by at least one stable intermediate or cofactor molecule. The c-myc autoregulatory mechanism was found operative in all (11 of 11) non-tumorigenic cells tested, including normal and immortalized lymphocytes and fibroblasts. However, this mechanism was found to be inactive in all (10 of 10) tumor cell lines derived from a variety of tissues including those carrying normal and oncogenically activated c-myc genes. These data establish the existence of an important regulatory circuit modulating c-myc expression in normal cells and suggest that its inactivation may represent a general regulatory disturbance of transformed cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249657      PMCID: PMC552162          DOI: 10.1002/j.1460-2075.1990.tb07612.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

1.  DNA-binding motif.

Authors:  G C Prendergast; E B Ziff
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.

Authors:  J Campisi; H E Gray; A B Pardee; M Dean; G E Sonenshein
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

4.  Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

Authors:  G L Shen-Ong; E J Keath; S P Piccoli; M D Cole
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Viral transduction of c-myc gene in naturally occurring feline leukaemias.

Authors:  J I Mullins; D S Brody; R C Binari; S M Cotter
Journal:  Nature       Date:  1984 Apr 26-May 2       Impact factor: 49.962

6.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Authors:  R Dalla-Favera; M Bregni; J Erikson; D Patterson; R C Gallo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

Review 7.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

8.  Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.

Authors:  K Nishikura; A ar-Rushdi; J Erikson; R Watt; G Rovera; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

9.  Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals.

Authors:  E J Keath; P G Caimi; M D Cole
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

10.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.

Authors:  O Bernard; S Cory; S Gerondakis; E Webb; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  31 in total

1.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

2.  Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene.

Authors:  P Spegelaere; B van Hille; N Spruyt; S Faisst; J J Cornelis; J Rommelaere
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 3.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 4.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

5.  Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.

Authors:  A Zentella; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

6.  YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels.

Authors:  A Shrivastava; J Yu; S Artandi; K Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.

Authors:  F Grignani; U Testa; D Rogaia; P F Ferrucci; P Samoggia; A Pinto; D Aldinucci; V Gelmetti; M Fagioli; M Alcalay; J Seeler; F Grignani; I Nicoletti; C Peschle; P G Pelicci
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

Review 8.  MYC association with cancer risk and a new model of MYC-mediated repression.

Authors:  Michael D Cole
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

9.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.